Results 141 to 150 of about 103,481 (331)

The agonist activities of the putative antipsychotic agents, L‐745,870 and U‐101958 in HEK293 cells expressing the human dopamine D4.4 receptor [PDF]

open access: green, 1998
Lucien Gazi   +9 more
openalex   +1 more source

Opicapone in Parkinson's Disease on Levodopa‐Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Levodopa‐carbidopa intestinal gel infusion (LCIG) is an effective therapy for advanced Parkinson's disease (PD). Opicapone (OPC) is an enzyme inhibitor that enhances the bioavailability of levodopa in the brain. Objectives This study evaluates the effect of Opicapone addition in PD‐LCIG patients, assessing its impact on motor ...
Fabiana Colucci   +9 more
wiley   +1 more source

Longitudinal Study of Treatment Variability for Parkinson's Disease across Specialized Centers

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Real‐world evidence on treatment practices in Parkinson's disease (PD) has been limited due to the difficulty in collecting comprehensive and generalizable clinical data. Objectives We sought to identify treatment patterns and test how treatment changed in response to (1) falling, (2) worsening disease, and (3) worsening quality of ...
Nabila Dahodwala   +11 more
wiley   +1 more source

Metabolic effects of prolactin and the role of dopamine agonists: A review. [PDF]

open access: yesFront Endocrinol (Lausanne), 2022
Kirsch P, Kunadia J, Shah S, Agrawal N.
europepmc   +1 more source

Dopaminergic Regulation of Neuronal Circuits in Prefrontal Cortex [PDF]

open access: yes, 2001
Neuromodulators, like dopamine, have considerable influence on the\ud processing capabilities of neural networks. \ud This has for instance been shown in the working memory functions\ud of prefrontal cortex, which may be regulated by altering the\ud ...
Scheler, Gabriele
core  

Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS‐Park Cohort

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Impulse control disorders (ICD) are common non‐motor complications in Parkinson's disease (PD), particularly in patients receiving oral dopamine agonists (DA). Continuous subcutaneous apomorphine infusion (CSAI) is a device‐aided therapy for advanced PD, but its effects on ICD remain underexplored in real‐world settings.
Clément Desjardins   +249 more
wiley   +1 more source

Home - About - Disclaimer - Privacy